This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Bull & Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty in connection with the proposed acquisition of Genoptix, Inc. (NASDAQ:
News) (referred to as "Genoptix" or the “Company”) by Novartis Finance Corporation (“Novartis”) in a cash transaction valued at approximately $470 million and an enterprise value of $330 million.
Under the terms of the merger agreement, Novartis will commence an all cash tender offer for all outstanding shares of common stock of Genoptix at $25.00 per share.